Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1100 µg Brimonidine Tartrate Implant1件: Brimonidine (Brimonidine Tartrate Ophthalmic Solution)1件: Brimonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
2200 µg Brimonidine Tartrate Implant1件: Brimonidine (Brimonidine Tartrate Ophthalmic Solution)1件: Brimonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
3400 µg Brimonidine Tartrate Implant1件: Brimonidine (Brimonidine Tartrate Ophthalmic Solution)1件: Brimonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
4Brimonidine tartrate1件: Brimonidine (Brimonidine Tartrate Ophthalmic Solution)1件: Brimonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90 💬
5Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System1件: Brimonidine (Brimonidine Tartrate Ophthalmic Solution)1件: Brimonidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬